X-Machina: A Promising Private AI Company Set To Soon Go Public – The Daily Dive

It’s a treat for AI enthusiasts today on the Daily Dive as we welcome on the show for the first time Claude Theoret, founder and CEO of AI-focused holdings firm Xmachina.

Claude joins us to discuss AI and deep learning (0:52), as well as the status and prospects of the industry (3:47). He also shares an overview of Xmachina (6:40), the process behind its acquisition strategy (9:40), and how Claude became an astrophysicist-turned-entrepreneur (12:15).

Xmachina-AI differentiates itself by acting as a holding company for early to mid-stage AI companies rather than acquiring late-stage companies. The firm provides the companies with resources, growing them to be 100%-owned subsidiaries in the future. Currently, it is focused on enhancing supply-chain efficiencies, logistics and manufacturing among its portfolio holdings.


FULL DISCLOSURE: Canacom Group, the parent company of The Deep Dive, is currently long the equity of XMachina. Not a recommendation to buy or sell. We may buy or sell securities in the company at any time. Always do additional research and consult a professional before purchasing a security.

Video Articles

Gold Isn’t In A Bubble, Currency Is. – Doug Casey

The Real Move Begins When They Cut Rates | Peter Krauth

Is Altamira Gold Sitting On Brazil’s Next Big Gold Discovery?

Recommended

Stifel Initiates Coverage On Goliath Resources With $5.00 Price Target

ESGold Completes Mill Building Construction, Final Equipment Procurement Underway

Related News

Is There A Growing Demand For Nuclear Energy? – The Daily Dive

The Daily Dive is starting off this week with a new guest, Scott Melbye, CEO...

Monday, November 8, 2021, 01:30:00 PM

What’s The Market Safe Haven Now? – The Daily Dive

We’re capping off this week with a Daily Dive interview featuring returning guest Will Rhind,...

Friday, December 10, 2021, 01:30:00 PM

A Medical Breakthrough the Market Overlooked | David Elsley – Cardiol Therapeutics

In this interview David Elsley, CEO of Cardiol Therapeutics (NASDAQ: CRDL) (TSXV: CRDL), shares some...
Monday, August 18, 2025, 03:53:00 PM

The Uranium Supply Squeeze Will Just Get Tighter — With Scott Melbye

Joining us today on the Daily Dive is Scott Melbye, CEO of Uranium Royalty Corp...

Thursday, December 1, 2022, 01:30:00 PM

Silver Supply Run: Big Tech To Trigger A Silver Supply Shock | Keith Neumeyer – First Majestic

In this interview, Keith Neumeyer, President & CEO of First Majestic Silver Corp. (NYSE: AG)...
Sunday, January 12, 2025, 01:28:00 PM